Global Breast Cancer Gene (BRCA) Mutations Treatment Market Report 2026–2035: Key Forecasts and Growth Areas

Uncover key drivers, emerging technologies, and competitive movements shaping the breast cancer gene (brca) mutations treatment market from 2026–2035 with trusted insights from The Business Research Company

How much is the Breast Cancer Gene (BRCA) Mutations Treatment Market valued at in 2026, and what valuation is forecast for 2030?

The breast cancer gene (brca) mutations treatment market size has experienced significant growth in recent years. It is anticipated to increase from $5.01 billion in 2025 to $5.37 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. The expansion observed in prior periods can be linked to factors like a scarcity of information concerning brca mutations, limited accessibility to genetic testing services, a reliance on traditional chemotherapy, an escalating occurrence of breast and ovarian cancer, and the progressive adoption of targeted therapies.

The market for treating breast cancer gene (brca) mutations is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. The anticipated growth during this period is attributable to several factors, including progress in genomic sequencing technologies, the broadened applications of parp inhibitor indications, increasing financial commitments to precision oncology, a rise in the use of combination therapies, and favorable reimbursement policies for both genetic testing and targeted treatments. Key trends expected over the forecast horizon encompass the increasing uptake of genetic testing and early brca mutation screening, an expanded role for parp inhibitors in targeted therapy, a heightened emphasis on preventive and risk-reduction treatment strategies, the proliferation of personalized and precision oncology methods, and enhanced availability of multimodal treatment options for brca-related cancers.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27231&type=smp

What Drivers Are Influencing The Growth Of The Breast Cancer Gene (BRCA) Mutations Treatment Market?

The growing need for targeted therapies is anticipated to boost the breast cancer gene (BRCA) mutation treatment market moving forward. Targeted therapies are medical interventions designed to precisely attack cancer cells by concentrating on genetic mutations or proteins contributing to cancer development. The increased preference for targeted therapies stems from their capacity to specifically target disease-causing cells or molecules, thereby reducing harm to healthy tissues. This leads to enhanced treatment efficacy and fewer adverse reactions compared to conventional treatments. Such therapies aid in managing breast cancer gene (BRCA) mutations by providing precision medicines that directly address the genetic changes driving the condition, thus improving treatment results and lessening unwanted side effects. For example, in July 2023, a report from the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, indicated that there were 247 gene therapies in Phase II at the end of Q1 2023. This figure saw a 5% increase, reaching 260 by the close of Q2 2023. Consequently, the rising demand for targeted therapies is propelling the expansion of the breast cancer gene (BRCA) mutation treatment market.

How Is The Breast Cancer Gene (BRCA) Mutations Treatment Market Organized Into Various Segments?

The breast cancer gene (brca) mutations treatment market covered in this report is segmented –

1) By Treatment Type: Targeted Therapies, Chemotherapy, Hormonal Therapy, Immunotherapy

2) By Indication: Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer

3) By Administration Route: Oral, Intravenous, Subcutaneous

4) By End-User: Hospitals, Clinics, Cancer Specialty Clinics

Subsegments:

1) By Targeted Therapies: Poly (ADP-Ribose) Polymerase Inhibitors, Mammalian Target Of Rapamycin Inhibitors, Cyclin-Dependent Kinase 4 And 6 Inhibitors, Tyrosine Kinase Inhibitors

2) By Chemotherapy: Platinum-Based chemotherapy, Anthracyclines, Taxanes, Antimetabolites

3) By Hormonal Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Selective Estrogen Receptor Degraders (SERDs), Luteinizing Hormone-Releasing Hormone (LHRH) Agonists

4) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Monoclonal Antibodies

Who Are The Primary Competitors In The Global Breast Cancer Gene (BRCA) Mutations Treatment Market?

Major companies operating in the breast cancer gene (brca) mutations treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GSK plc, Janssen Biotech Inc., Astellas Pharma Inc., Genentech Inc., Clovis Oncology Inc., Owkin Inc., Allarity Therapeutics Inc., VBL Therapeutics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/breast-cancer-gene-brca-mutations-treatment-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Breast Cancer Gene (BRCA) Mutations Treatment Market?

North America was the largest region in the breast cancer gene (BRCA) mutations treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer gene (brca) mutations treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Breast Cancer Gene (BRCA) Mutations Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27231&type=smp

Browse Through More Reports Similar to the Global Breast Cancer Gene (BRCA) Mutations Treatment Market 2026, By The Business Research Company

Converted Paper Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/converted-paper-products-global-market-report

Decorative Concrete Market Report 2026

https://www.thebusinessresearchcompany.com/report/decorative-concrete-global-market-report

Concrete Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/concrete-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795